CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 149 enrolled
Drug / intervention
Device: Smartphone +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01952041
NCT01952041N/ACompleted

A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia

Dartmouth-Hitchcock Medical Center·interventional·Posted Sep 27, 2013·Updated Jun 21, 2019

In Brief

A clinical study evaluating Device: Smartphone and Treatment as usual for Schizophrenia and Schizoaffective Disorder. Completed, enrolled 149 participants across 1 site.

Detailed Summary

This study was a 2-arm randomized control trial (RCT) designed to test a multi-modal smartphone data collection system that provided mobile monitoring of schizophrenia to detect early signs of relapse. The RCT compared an arm with participants who received treatment as usual with an arm that received the smartphone system for a year.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 27, 2013
Enrollment StartMar 13, 2015
Primary CompletionAug 7, 2017
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 12.8 years ago

Interventions

Device: Smartphonebehavioral

Treatment as usualbehavioral